健肝消脂颗粒对非酒精性脂肪肝胰岛素抵抗的影响研究
DOI:
作者:
作者单位:

1. 云南中医学院第三附属医院,云南昆明 650011;2. 云南中医学院中药学院,云南昆明 650500; 3. 襄阳市中心医院,湖北襄阳 441000;4. 湖北中医药大学基础医学院,湖北武汉 430061; 5. 云南中医学院第一附属医院,云南昆明 650021

作者简介:

通讯作者:

中图分类号:

R256.4

基金项目:

基金项目: 云南白药、云南中医学院中医药教育创新基金项目(00360504209) 收稿日期: 2013 - 05 - 27 作者简介: 刘俊(1984-),男,湖北襄阳人,住院医师,从事中医内科学老年病的防治与研究。 △通信作者:温伟波,E-mail:85092344@qq.com.


The Research of the Effect of the Liver-invigorating and Fat-reducing Particles to the Insulin Resistance of the Nonalcoholic Fatty Liver Disease
Author:
Affiliation:

1. The Third Affiliated Hospital of Yunnan University of TCM, Kunming 650000, China; 2. Yunnan University of TCM, Kunming 650500, China; 3. Department of Cardiothoracic Surgery of Xiangyang Central Hospital of Hubei Province, Xiangyang 441000, China; 4

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
    摘要:

    目的主要研究健肝消脂颗粒治疗NAFLD胰岛素抵抗的疗效。方法将患者分为治疗组与对照组,观察分析两者IR,ALT、AST、GGT,TG、TC、LDL-C,WC、BW、BMI的改善情况。结果1. 两组IRI变化程度的差异有显著性意义(P<0.01),治疗组显著优于对照组。2. 两组ALT、AST、GGT下降的差异无统计学意义(P>0.05)。3. 两组TG、TC下降的差异有显著性意义(P<0.01),LDL-C下降的差异无统计学意义(P>0.05),治疗组显著优于对照组。4. 两组WC下降的差异有统计学意义(P<0.05),BW下降的差异无统计学意义(P>0.05),BMI下降的差异有显著性意义(P<0.01),治疗组优于对照组。结论健肝消脂颗粒可以有效治疗NAFLD,可以改善其IR,可以降低ALT、AST、GGT,TG、TC,WC、BMI水平。

    Abstract:

    Objective The main purpose is to research the curative effect of the liver-invigorating and fat-reducing particles to the insulin resistance of nonalcoholic fatty liver disease. Methods Take patients into two groups, to observe curative effect between two groups, to analyze the reducing of insulin resistance, ALT, AST, GGT, TG, TC, LDL-C, WC, BW, BMI. Results 1. The difference between two groups′ reducing extent of IRI is significant(P<0.01), treatment group is much better than control group. 2. The difference between two groups′ reducing extent of ALT, AST and GGT(P>0.05)are not statistically significant. 3. The difference between two groups′ reducing extent of TG, TC are significant(P<0.01), and the difference between two groups′ reducing extent of LDL-C is not statistically significant(P>0.05), treatment group is much better than control group. 4. The difference between two groups′ reducing extent of WC is statistically significant(P<0.05), the difference between two groups′ reducing extent of BW is not statistically significant(P>0.05), the difference between two groups′ reducing extent of BMI is significant (P<0.01), treatment group is better than control group. Conclusion Liver-invigorating and fat-reducing particles can relieve the nonalcoholic fatty liver disease, and relieve the insulin resistant. It can also reduce the level of ALT, AST, GGT, TG, TC, WC, BMI.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期:

温馨提示

关闭